Evaluation of local effect of Oxybutynin in treatment of palmar hyperhidrosis

Phase 3

Recruiting

• Conditions: Primary palmar hyperhidrosis.; Primary focal hyperhidrosis, palms; L74.512

• Registration Number: IRCT20210822052255N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Older than 18 years of age patients with primary palmar hyperhidrosis
Patients should have ability to understand Persian language of written consent and questionnaire to participate in the study
All topical and oral treatments should be discontinued for at least 4 weeks before beginning of the study, except for Botox injections, which should not have been injected in the past 12 weeks.

Exclusion Criteria

Reluctance to cooperate
Hypersensitivity to topical Oxybutynin
Pregnancy and lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hyperhidrosis Disease Severity Index (HDSS). Timepoint: Before intervention and one month after starting intervention. Method of measurement: Hyperhidrosis Disease Severity Index (HDSS) score formula.

Secondary Outcome Measures

Name	Time	Method
Dermatology Life Quality Index (DLQI). Timepoint: Before intervention and one month after starting intervention. Method of measurement: Dermatology Life Quality Index (DLQI) formula score.